Zhejiang Orient Gene Biotech Co.,Ltd. has announced that the company, along with its wholly-owned subsidiary Healgen Scientific LLC and its controlled subsidiary Hangzhou Danwei Biotechnology Co., Ltd., has recently obtained medical device product registration certificates for several products.

Domestically, the company has secured registrations for its Hepatitis C Virus (HCV) Antibody Detection Reagent (Colloidal Gold Method), Helicobacter Pylori (H.P) Antigen Detection Reagent (Latex Method), and Bordetella Pertussis Nucleic Acid Detection Kit (Fluorescent PCR Method). These certifications further complete the company's portfolio of infectious disease detection products and enhance the categories and technological pathways of its key respiratory detection product series. This development is conducive to the overall expansion of the domestic infectious disease market and strengthens the focus on detecting seasonal respiratory infections.

Furthermore, several other products have obtained certifications in regions including the European Union and the United States. This further enriches and improves the company's product series layout in these countries and regions, benefiting the overall expansion of the European and American markets.